Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > IMMX Immix Biopharma > Detailed Quotes

IMMX Immix Biopharma

Watchlist
2.6000.0000.00%
Close 07/01 16:00 ET
2.550
-0.05-1.92%
Post Mkt Price 07/01 19:59 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
2.650
Open
2.420
Turnover
711.37K
Low
2.420
Pre Close
2.600
Volume
277.90K
Market Cap
40.48M
P/E(TTM)
Loss
52wk High
8.680
Shares
15.57M
P/E(Static)
Loss
52wk Low
1.250
Float Cap
18.52M
Bid/Ask %
97.89%
Historical High
8.680
Shs Float
7.12M
Volume Ratio
0.72
Historical Low
1.250
Dividend TTM
--
Div Yield TTM
--
P/B
2.06
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.90%
Amplitude
8.85%
Avg Price
2.559
Lot Size
1
Float Cap
18.52M
Bid/Ask %
97.89%
Historical High
8.680
Shs Float
7.12M
Volume Ratio
0.72
Historical Low
1.250
Dividend TTM
--
P/B
2.06
Dividend LFY
--
Turnover Ratio
3.90%
Amplitude
8.85%
Avg Price
2.559
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn’s disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
CEO: Rachman M.B.A., M.D., MBA, Ph.D., Ilya
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top